These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 4147388)

  • 1. Derivatives of 3,4-dihydro-1(2H)-naphthalenone as beta-adrenergic blocking agents. 2. Aromatic-substituted analogs of bunolol.
    Schwender CF; Pike RE; Shavel J
    J Med Chem; 1973 Mar; 16(3):254-7. PubMed ID: 4147388
    [No Abstract]   [Full Text] [Related]  

  • 2. Derivative of 3,4-dihydro-1(2H)-naphthalenone as -adrenergic blocking agents. 3. Carbonyl-containing analogs of bunolol.
    Schwender CF; Pike RE; Sunday BR; Shavel J
    J Med Chem; 1973 May; 16(5):585-8. PubMed ID: 4146254
    [No Abstract]   [Full Text] [Related]  

  • 3. Antiarrhythmic and general cardiovascular activity of the N,N-dimethylquaternary ammonium derivative of bunolol.
    Kaplan HR; Barker JW; Dugan D; Fox J; Giardino E
    Arch Int Pharmacodyn Ther; 1974 Jan; 207(1):28-43. PubMed ID: 4151048
    [No Abstract]   [Full Text] [Related]  

  • 4. Beta-adrenergic blockade by 3-[3-(substituted amino)-2-hydroxypropox]-5-hydroxybenzyl alcohols.
    Schwender CF; Pike RE; Shavel J
    J Med Chem; 1975 Feb; 18(2):211-3. PubMed ID: 235645
    [No Abstract]   [Full Text] [Related]  

  • 5. Synthesis and pharmacological evaluation of novel potential ultrashort-acting beta-blockers.
    Mokrý P; Zemanová M; Csöllei J; Racanská E; Tumová I
    Pharmazie; 2003 Jan; 58(1):18-21. PubMed ID: 12622246
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Derivatives of 3,4-dihydro-1(2H)-naphthalenone as beta-adrenergic blocking agents. I. Bunolol and related analogs.
    Schwender CF; Farber S; Blaum C; Shavel J
    J Med Chem; 1970 Jul; 13(4):684-8. PubMed ID: 4393796
    [No Abstract]   [Full Text] [Related]  

  • 7. Studies of 1-(o-cyclopropylphenoxy)-3-isopropylamino-2-propanol, a new -adrenergic blocking drug.
    Boissier JR; Giudicelli JF; Viars P; Advenier C; Mouille P; Larno S
    Eur J Pharmacol; 1971 Jul; 15(2):151-9. PubMed ID: 4403548
    [No Abstract]   [Full Text] [Related]  

  • 8. Beta-adrenoceptor studies. 1. In vitro beta-adrenergic blocking, antiarrhythmic, and local anesthetic activities of a new series of aromatic bis(2-hydroxy-3-isopropylaminopropyl) ethers.
    Zaagsma J; Nauta WT
    J Med Chem; 1974 May; 17(5):507-13. PubMed ID: 4151492
    [No Abstract]   [Full Text] [Related]  

  • 9. The antiarrhythmic effects of quaternary salts of beta-adrenergic blocking agents.
    Lahiri PK; Hardman HF
    Arch Int Pharmacodyn Ther; 1974 Aug; 210(2):197-211. PubMed ID: 4155279
    [No Abstract]   [Full Text] [Related]  

  • 10. Derivatives of 3,4-dihydrocarbostyril as beta-adrenergic blocking agents.
    Nakagawa K; Murakami N; Yoshizaki S; Tominaga M; Mori H
    J Med Chem; 1974 May; 17(5):529-33. PubMed ID: 4151493
    [No Abstract]   [Full Text] [Related]  

  • 11. 1-Alkylamino-3-(2-thiazolyloxy)-2-propanols. A novel class of mixed myocardial beta-stimulants-beta-blockers.
    Edwards JA; Berkoz B; Lewis GS; Halpern O; Fried JH; Strosberg AM; Miller LM; Urich S; Liu F; Roszkowski AP
    J Med Chem; 1974 Feb; 17(2):200-3. PubMed ID: 4148933
    [No Abstract]   [Full Text] [Related]  

  • 12. l-Bunolol and propranolol: oral and intravenous beta-adrenoceptor blocking activity in rats compared to dogs and humans.
    Kaplan HR; Commarato MA; Lattime EC
    J Pharm Sci; 1978 Jan; 67(1):132-3. PubMed ID: 22739
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A new series of cardioselective adrenergic beta-receptor blocking compounds. 1-(2-Acyl-4-acylaminophenoxy)-3-isopropylaminopropan-2-ols.
    Basil B; Clark JR; Coffee EC; Jordon R; Loveless AH; Pain DL; Wooldridge KR
    J Med Chem; 1976 Mar; 19(3):399-402. PubMed ID: 3647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Levo-bunolol and propranolol: further evaluation of oral beta-blocking activity in conscious dogs.
    Commarato MA; Giardino EC; Kopia GA; Kaplan HR
    Arch Int Pharmacodyn Ther; 1977 Apr; 226(2):205-13. PubMed ID: 327960
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity in new -adrenergic blocking agents. (3-Amino-2-hydroxypropoxy)benzamides.
    Shtacher G; Erez M; Cohen S
    J Med Chem; 1973 May; 16(5):516-9. PubMed ID: 4146253
    [No Abstract]   [Full Text] [Related]  

  • 16. Effect of o-2-hydroxy-3-(tert.-butylamino) propoxybenzonitrile HCl (KO 1366) on beta adrenergic receptors in the cardiovascular system.
    Nayler WG; Tay J
    J Pharmacol Exp Ther; 1972 Feb; 180(2):302-16. PubMed ID: 4400889
    [No Abstract]   [Full Text] [Related]  

  • 17. Relative beta adrenergic receptor blocking activity in dogs after intravenous and intraportal vein administration: bunolol, propranolol, their levo isomers and sotalol.
    Kaplan HR; Commarato MA
    J Pharmacol Exp Ther; 1973 May; 185(2):395-405. PubMed ID: 4145046
    [No Abstract]   [Full Text] [Related]  

  • 18. Beta adrenergic blockade on intramyocardial distribution of coronary blood flow.
    Gross GJ; Winbury MM
    J Pharmacol Exp Ther; 1973 Dec; 187(3):451-64. PubMed ID: 4149128
    [No Abstract]   [Full Text] [Related]  

  • 19. N-substituted 2-amino-1-(2-thienyl)ethanols as beta-adrenergic blocking agents.
    Corral C; Darias V; Fernández-Tomé MP; Madroñero R; Del Río J
    J Med Chem; 1973 Aug; 16(8):882-5. PubMed ID: 4147684
    [No Abstract]   [Full Text] [Related]  

  • 20. Pharmacological effects of two new -adrenoceptor blocking drugs: Kö 1366 and Kö 1313.
    Cheymol G; Honnorat C; Schmitt H
    Eur J Pharmacol; 1972 Mar; 17(3):341-51. PubMed ID: 4401812
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.